Sort by
Refine Your Search
-
improvements in different production traits. In parallel, a single cell atlas for turkey immune organs will be developed for use in downstream gene editing applications. Learning Objectives: The fellow will
-
strategies to improve safety and efficacy of T cell therapies. Learning Objectives: The overall learning experiences you will gain are as follows: Will learn to perform laboratory research on projects related
-
, cell-based assays, and quantitative immunologic methods to measure functional antibody activity. Learning Objectives: Under the guidance of a mentor, you will have the opportunity to: Learn
-
background in computational biology, modeling or Machine Learning and Artificial Intelligence Familiarity with basic techniques and principles in cell and molecular biology and biochemistry Willing to learn
-
of biologics. The study design involves using currently available model viruses to spike into a complex cell material and performing the various steps in the NGS workflow including laboratory research and
-
. Learning Objectives: Under the guidance of a mentor, you will engage in learning research focused on understanding antibody responses to conserved and variable epitopes in rapidly evolving RNA viruses, with
-
...on the GO! Download the new ORISE GO mobile app in the Apple App Store or Google Play Store to help you stay engaged, connected, and informed during your ORISE experience and beyond!” Application Deadline
-
host immune system. These responses are frequently HLA-restricted and mediated by T cell receptor (TCR) recognition. Learning Objectives: Under the guidance of FDA scientists, you will gain
-
JW, Surov SS, Liang Y, Parunov LA, Ovanesov MV. Effect of pH on thrombin activity measured by calibrated automated thrombinography. Res Pract Thromb Haemost. 2020 Jun 12;4(5):944-945. Learning
-
of Bacterial Polysaccharides, Vaccine Structure Group. The successful candidate will learn from an experienced research team and investigate the structural aspects of glycoconjugate based vaccines